Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.

The FDA rejected sotagliflozin 5 years ago for the same indication but for the broader population of adults with T1D, due to ...

Adult diabetes cases worldwide have more than quadrupled, according to a new analysis from The Lancet journal.

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney ...

People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal ...